BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 12897038)

  • 1. Hypothesis: vitamin E complements polyunsaturated fatty acids in essential fatty acid deficiency in cystic fibrosis.
    Wood LG; Fitzgerald DA; Garg ML
    J Am Coll Nutr; 2003 Aug; 22(4):253-7. PubMed ID: 12897038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No indications for altered essential fatty acid metabolism in two murine models for cystic fibrosis.
    Werner A; Bongers ME; Bijvelds MJ; de Jonge HR; Verkade HJ
    J Lipid Res; 2004 Dec; 45(12):2277-86. PubMed ID: 15466369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of decreased hepatic lipase activity and lipoprotein abnormalities to essential fatty acid deficiency in cystic fibrosis patients.
    Lévy E; Lepage G; Bendayan M; Ronco N; Thibault L; Galéano N; Smith L; Roy CC
    J Lipid Res; 1989 Aug; 30(8):1197-209. PubMed ID: 2769073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal unsaturated fatty acid metabolism in cystic fibrosis: biochemical mechanisms and clinical implications.
    Seegmiller AC
    Int J Mol Sci; 2014 Sep; 15(9):16083-99. PubMed ID: 25216340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The deltaF508 mutation in the cystic fibrosis transmembrane conductance regulator alters control of essential fatty acid utilization in epithelial cells.
    Bhura-Bandali FN; Suh M; Man SF; Clandinin MT
    J Nutr; 2000 Dec; 130(12):2870-5. PubMed ID: 11110839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ursodeoxycholic acid improves the hepatic metabolism of essential fatty acids and retinol in children with cystic fibrosis.
    Lepage G; Paradis K; Lacaille F; Sénéchal L; Ronco N; Champagne J; Lenaerts C; Roy CC; Rasquin-Weber A
    J Pediatr; 1997 Jan; 130(1):52-8. PubMed ID: 9003851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Δ5- and Δ6-desaturase, cyclooxygenase-2, and lipoxygenase-5 expression and activity are associated with fatty acid and eicosanoid changes in cystic fibrosis.
    Njoroge SW; Seegmiller AC; Katrangi W; Laposata M
    Biochim Biophys Acta; 2011; 1811(7-8):431-40. PubMed ID: 21605700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective essential-fatty-acid metabolism in cystic fibrosis.
    Rivers JP; Hassam AG
    Lancet; 1975 Oct; 2(7936):642-3. PubMed ID: 52009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin E.
    Bieri JG; Farrell PM
    Vitam Horm; 1976; 34():31-75. PubMed ID: 828356
    [No Abstract]   [Full Text] [Related]  

  • 10. Glued in lipids: Lipointoxication in cystic fibrosis.
    Vandebrouck C; Ferreira T
    EBioMedicine; 2020 Nov; 61():103038. PubMed ID: 33038767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyunsaturated fatty acids in the low-birth-weight infant.
    Friedman Z
    Semin Perinatol; 1979 Oct; 3(4):341-61. PubMed ID: 395645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Airway nitric oxide in patients with cystic fibrosis is associated with pancreatic function, Pseudomonas infection, and polyunsaturated fatty acids.
    Keen C; Olin AC; Edentoft A; Gronowitz E; Strandvik B
    Chest; 2007 Jun; 131(6):1857-64. PubMed ID: 17400678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential fatty acid deficient rats in the study of cystic fibrosis: an X-ray microanalytical and ultrastructural study in chronically reserpinized rats.
    Hjelte L; Strandvik B; Müller RM; Sagström S; Roomans GM
    J Submicrosc Cytol Pathol; 1990 Jul; 22(3):409-14. PubMed ID: 2390763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role for animal models in understanding essential fatty acid deficiency in cystic fibrosis.
    Hryciw DH; Jackson CA; Shrestha N; Parsons D; Donnelley M; McAinch AJ
    Cell Mol Life Sci; 2021 Dec; 78(24):7991-7999. PubMed ID: 34741185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific changes in n -6 fatty acid metabolism in patients with chronic intestinal failure.
    Chambrier C; Garcia I; Bannier E; Gerard-Boncompain M; Bouletreau P
    Clin Nutr; 2002 Feb; 21(1):67-72. PubMed ID: 11884015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal dietary zinc deficiency in artificially reared rat pups retards behavioral development and interacts with essential fatty acid deficiency to alter liver and brain fatty acid composition.
    Wauben IP; Xing HC; Wainwright PE
    J Nutr; 1999 Oct; 129(10):1773-81. PubMed ID: 10498747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of essential fatty acid deficiency in cystic fibrosis despite nutritional therapy.
    Aldámiz-Echevarría L; Prieto JA; Andrade F; Elorz J; Sojo A; Lage S; Sanjurjo P; Vázquez C; Rodríguez-Soriano J
    Pediatr Res; 2009 Nov; 66(5):585-9. PubMed ID: 19851226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manipulation of the acute inflammatory response by dietary polyunsaturated fatty acid modulation.
    Lefkowith JB; Morrison A; Lee V; Rogers M
    J Immunol; 1990 Sep; 145(5):1523-9. PubMed ID: 2166763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder.
    Burgess JR; Stevens L; Zhang W; Peck L
    Am J Clin Nutr; 2000 Jan; 71(1 Suppl):327S-30S. PubMed ID: 10617991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of essential fatty acids in cystic fibrosis and normalizing effect of fenretinide.
    Garić D; Dumut DC; Shah J; De Sanctis JB; Radzioch D
    Cell Mol Life Sci; 2020 Nov; 77(21):4255-4267. PubMed ID: 32394023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.